Cannabis Stocks Icon

Cannabis Stocks

Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.

Recent Cannabis Stocks Articles

Is Canopy Growth Stock the Best Cannabis Play?

CGC stock has roughly doubled from its December lows to its January highs. Canopy Growth is good, but it needs time to digest that big rally.

As Cronos Stock Skyrockets, Should Investors Be Afraid?

Cronos shares have been climbing for months after Altria invested billions in the firm. Is it time to lock in CRON stock profits?

Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?

With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.

Is Aurora Cannabis Stock Worth a Buy on Stratospheric Sales?

Aurora Cannabis stock investors had mixed reactions to ACB's fiscal quarter results. Here's what you need to know about the company's results.

Should You Chase the Big Rally In Pyxus Stock?

Pyxus stock popped more than 25% after Q3 earnings, but fundamental challenges will likely cap further upside.

Are Marijuana Stocks Generally Overvalued?

Marijuana stocks like Aurora, Tilray and Canopy Growth have had a great past few months, but the reality is going to set in sooner or later.

Cannabis Stocks: Do Aurora or Canopy Earnings Matter?

Marijuana stocks like Aurora and Canopy Growth are highly volatile, and speculators would be to wise to buy only when they're down.

Amyris Stock Can Run Much Higher Than You Think

Amyris' move into cannabis has turned AMRS stock into a marijuana equity, and hemp legalization will help propel AMRS to multi-year highs.

Why Aurora Cannabis Stock Will Be the Biggest Winner – or the Biggest Loser – in Pot

Aurora Cannabis stock has risen nicely in 2019. But longer-term, ACB stock is likely to be either a big winner or a big loser.

It’s Time for Cronos Stock to Dive Back Down to Reality

The CRON stock price has gone parabolic, which means we all know how the party will end for Cronos Group.

Ride Cronos Stock’s Meteoric Rise … Before You Can’t

CRON is a hyper-momentum stock and there's no perfect time to buy it. Valuation aside, cannabis investing is young and the potential is great.

CRON Could Retest its $10 December Low

This morning I am recommending a bearish trade on Cronos Group, Inc. (NASDAQ:CRON), the Canada-based cannabis company.

Marijuana and Electric Car Trends Build Momentum

Volatile stock price swings characterize growth investing, but recent news confirms marijuana and next-generation battery trends.

You Can Trust Aurora Cannabis Stock Despite the Dilution

Dilutive acquisitions may hurt ACB stock in the nearer-term, but management is making the necessary moves for future success.

2 Wall Street Giants ‘All In’ for This Investment Trend

Electric Cars and Legalized Marijuana -- Major Signs of Growth Yesterday, Volkswagen and Ford announced they'll be forming a global alliance that will focus on…

New Age Beverages Is 2019’s “If” Stock

New Age Beverages hopes people turn to new types of drinks in 2019, including some infused with cannabidiol (CBD). Should you buy NBEV stock?

How Tilray Stock Has Crushed Its Short Sellers

Tilray's major shareholder has said that they won't be selling any stock anytime soon. With that being the case, TLRY stock will make more gains.

Keeping Your Portfolio Safe as Earnings Disappointments Mount

Lowered earnings forecasts make a focus on quality critical in 2019 Yesterday, Macy's stock suffered its biggest one-day drop since going public 27 years ago.…

The 3 Strongest Marijuana Stocks to Buck Short-Term Paralysis

These three marijuana stocks to buy will keep powering through the ups and downs of the market, while many others will fall behind.